BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11189218)

  • 1. Cutaneous fungal infection caused by Fusarium solani.
    Yao Z; Liao W; Li Z; Xu H
    Chin Med J (Engl); 1998 Nov; 111(11):1054-6. PubMed ID: 11189218
    [No Abstract]   [Full Text] [Related]  

  • 2. Fusarium solani infection in a patient with acute myelogenous leukemia--a case report.
    Kumar RR; Kumar BR; Shafiulla M; Lakshmaiah KC; Sridhar H
    Indian J Pathol Microbiol; 1997 Oct; 40(4):555-7. PubMed ID: 9444872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation.
    Neuburger S; Massenkeil G; Seibold M; Lutz C; Tamm I; le Coutre P; Graf B; Doerken B; Arnold R
    Transpl Infect Dis; 2008 Jul; 10(4):290-3. PubMed ID: 18194367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
    Park SG; Oh SH; Suh SB; Lee KH; Chung KY
    Br J Dermatol; 2005 Mar; 152(3):560-4. PubMed ID: 15787829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microbiological and clinical aspects of antifungal therapy].
    Male O
    Adv Clin Pharmacol; 1977; 14():71-82. PubMed ID: 596274
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resolution of a disseminated infection by Fusarium solani in a patient with acute promyelocytic leukemia and granulocytopenia secondary to chemotherapy by the combined use of G-CSF and liposomal amphotericin B].
    Sancho JM; Ribera JM; Matas L; Batlle M
    Med Clin (Barc); 1997 Jun; 109(4):156-7. PubMed ID: 9289532
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B.
    Rothe A; Seibold M; Hoppe T; Seifert H; Engert A; Caspar C; Karthaus M; Fätkenheuer G; Bethe U; Tintelnot K; Cornely OA
    Ann Hematol; 2004 Jun; 83(6):394-7. PubMed ID: 14648020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
    Muramatsu T; Ueki T; Ohashi K; Negishi K; Suzuki T; Shitara M; Honma M; Ito T; Sakai M; Yamashita T; Akiyama H; Sakamaki H
    Rinsho Ketsueki; 2006 Aug; 47(8):753-7. PubMed ID: 16986714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.
    Guarro J; Pujol I; Mayayo E
    Antimicrob Agents Chemother; 1999 May; 43(5):1256-7. PubMed ID: 10223945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep cutaneous infection by Fusarium solani in a healthy child: successful treatment with local heat therapy.
    Nakamura Y; Xu X; Saito Y; Tateishi T; Takahashi T; Kawachi Y; Otsuka F
    J Am Acad Dermatol; 2007 May; 56(5):873-7. PubMed ID: 17147970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended fungal skin infection due to Aureobasidium pullulans.
    Pikazis D; Xynos ID; Xila V; Velegraki A; Aroni K
    Clin Exp Dermatol; 2009 Dec; 34(8):e892-4. PubMed ID: 20055859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous aspergillosis in a neonate.
    Gupta M; Weinberger B; Whitley-Williams PN
    Pediatr Infect Dis J; 1996 May; 15(5):464-5. PubMed ID: 8724074
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary cutaneous cryptococcosis successfully managed by surgical debridement and liposomal amphotericin B/flucytosine therapy.
    Tsuji G; Matsuda T; Shigyo A; Matsuda T; Furue M
    Eur J Dermatol; 2017 Feb; 27(1):96-97. PubMed ID: 27758760
    [No Abstract]   [Full Text] [Related]  

  • 14. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical and systemic antifungal agents.
    Bodey GP
    Med Clin North Am; 1988 May; 72(3):637-59. PubMed ID: 3280911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flucytosine dosing in an obese patient with extrameningeal cryptococcal infection.
    Gillum JG; Johnson M; Lavoie S; Venitz J
    Pharmacotherapy; 1995; 15(2):251-3. PubMed ID: 7624273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy in treatment of murine infection by Fusarium solani.
    Ruíz-Cendoya M; Mariné M; Guarro J
    J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peristomal cellulitis due to Magnusiomyces capitatus in a woman carrying percutaneous gastrostomy tube].
    Bartolomé J; Lozano MA; Lucena R; Candel FJ
    Rev Esp Quimioter; 2017 Feb; 30(1):59-61. PubMed ID: 28010055
    [No Abstract]   [Full Text] [Related]  

  • 19. Ulcerous lesions disclosing cutaneous infection with Fusarium solani.
    Pérez-Pérez L; Pereiro M; Sánchez-Aguilar D; Toribio J
    Acta Derm Venereol; 2007; 87(5):422-4. PubMed ID: 17721650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agent.
    Lodato F; Tamé MR; Montagnani M; Sambri V; Liguori G; Azzaroli F; Costigliola P; Grazi G; Roda E; Mazzella G
    Liver Transpl; 2006 Nov; 12(11):1711-4. PubMed ID: 17058254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.